Regenerative Medicine · Analysis
Mesenchymal Stem Cell Therapy for Cartilage Repair
Osteoarthritis management is limited to pain control and joint replacement, with no accessible regenerative option.
Principal investigator: Dr. Aisha Bello
Programme
40+
Active programmes across clinical, agri and environmental science
60+
Partner institutions, hospitals and grower networks
180
Peer-reviewed publications and field reports to date
Objectives
- Establish GMP-aligned MSC expansion
- Assess safety in a 60-patient trial
- Measure 24-month cartilage volume change
Methodology
- 1Autologous MSC isolation
- 2Phase I/II single-arm trial
- 3Quantitative MRI endpoints
Partners
- Orthopaedic Institute
- National Bioethics Committee
Publications
Safety of autologous MSC injection in knee osteoarthritis
Cell Therapy Reports · 2026
Connected
Laboratories and services behind this study
Research lifecycle
From a question worth asking to a result people can use
01
Scoping
Define the decision, the endpoint and the population or field site with our partners.
02
Protocol & ethics
Pre-registered protocol, ethics or biosafety approval and consent frameworks.
03
Execution
Accredited laboratory and field workflows with monitored data capture.
04
Translation
Peer-reviewed publication, regulatory dossiers and hand-off to service teams.
Partner with us
Collaborate on Mesenchymal Stem Cell Therapy for Cartilage Repair
Bring us a study, a sample set or a field problem. We scope feasibility, ethics and timelines within one working week.
Publications & data access
Request pre-prints, anonymised datasets or replication protocols from any completed programme.